Cosentyx

Active substance: secukinumab

secukinumab

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Composition

Analogues by country

Products with the same active substance registered in other countries.

Country	Products
RU 3	Козэнтикс раствор для подкожного введения, 150 мг/мл, 2 мл (original in Russian, GRLS) ЛП-№(008091)-(РГ-RU) Новартис Фарма АГ Козэнтикс раствор для подкожного введения, 150 мг/мл, 1 мл (original in Russian, GRLS) ЛП-003780 Новартис Фарма АГ Козэнтикс лиофилизат для приготовления раствора для подкожного введения, 150 мг, (original in Russian, GRLS) ЛП-003715 Новартис Фарма АГ
US 4	COSENTYX INJECTION · SECUKINUMAB 150 mg/mL 0078-0639 Novartis Pharmaceuticals Corporation COSENTYX INJECTION, SOLUTION, CONCENTRATE · SECUKINUMAB 25 mg/mL 0078-1168 Novartis Pharmaceuticals Corporation COSENTYX INJECTION · SECUKINUMAB 75 mg/.5mL 0078-1056 Novartis Pharmaceuticals Corporation COSENTYX INJECTION · SECUKINUMAB 300 mg/2mL 0078-1070 Novartis Pharmaceuticals Corporation

Country

Products

RU 3

Козэнтикс
раствор для подкожного введения, 150 мг/мл, 2 мл (original in Russian, GRLS)
ЛП-№(008091)-(РГ-RU)
Новартис Фарма АГ
Козэнтикс
раствор для подкожного введения, 150 мг/мл, 1 мл (original in Russian, GRLS)
ЛП-003780
Новартис Фарма АГ
Козэнтикс
лиофилизат для приготовления раствора для подкожного введения, 150 мг, (original in Russian, GRLS)
ЛП-003715
Новартис Фарма АГ

US 4

COSENTYX
INJECTION · SECUKINUMAB 150 mg/mL
0078-0639
Novartis Pharmaceuticals Corporation
COSENTYX
INJECTION, SOLUTION, CONCENTRATE · SECUKINUMAB 25 mg/mL
0078-1168
Novartis Pharmaceuticals Corporation
COSENTYX
INJECTION · SECUKINUMAB 75 mg/.5mL
0078-1056
Novartis Pharmaceuticals Corporation
COSENTYX
INJECTION · SECUKINUMAB 300 mg/2mL
0078-1070
Novartis Pharmaceuticals Corporation

Import and control

Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-91c0-73a3-9636-6b6f9bda892b,01a120c4-b7ba-77b7-817f-cd3b0ba3b3cb,01a120c5-b8c5-7097-b65c-2b277b80b81e;count=3 · valid from 2026-10-09 · verified 2026-10-09
United Statesprescription only
Source: openFDA NDC · record 01a1208c-4850-71d5-8e8d-d71d47662063,01a1208f-8d57-792c-bda2-406c88c004c2,01a12091-6ceb-7e58-bb40-20fd5ae562e8,01a12093-4261-7559-b6bd-7739c8e97463;count=4 · valid from 2026-10-09 · verified 2026-10-09